Apollo Global Management Insider Sold Shares Worth $173,477,024, According to a Recent SEC Filing-March 2024-www.financetom.com

Apollo Global Management Insider Sold Shares Worth $173,477,024, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Apollo Global Management Insider Sold Shares Worth $173,477,024, According to a Recent SEC Filing

Dec 5, 2024 12:40 AM

03:07 AM EST, 12/05/2024 (MT Newswires) -- Leon D Black, Co-Founder, Former Chief Executive Officer, on December 02, 2024, sold 1,000,000 shares in Apollo Global Management ( APO ) for $173,477,024. Following the Form 4 filing with the SEC, Black has control over a total of 40,604,773 shares of the company, with 35,104,773 shares held directly and 5,500,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1858681/000095014224002888/xslF345X05/es240564697_4-black.xml

Previous page： What's Going On With Hims & Hers Health Stock Monday? Next page：

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

What's Going On With Hims & Hers Health Stock Monday?

Nov 4, 2024

Hims & Hers Health ( HIMS ) shares are moving higher Monday ahead of earnings after the bell. Here’s what you need to know before the report. What To Know: Hims & Hers Health ( HIMS ) will report third-quarter financial results after the market close on Monday. Analysts expect the company to report earnings of 4 cents per share...

Nov 4, 2024

...

NeurAxis' IB-Stim Nerve Stimulator for Abdominal Pain Relief Gets New FDA Clearance

Nov 4, 2024

11:04 AM EST, 11/04/2024 (MT Newswires) -- NeurAxis (NRXS) said Monday it received a new 510(k) clearance from the US Food and Drug Administration for its IB-Stim nerve stimulator for functional abdominal pain relief, expanding its indication for use in people between 8 and 21 years of age from a previous indication for 11- to 18-year olds. IB-Stim is a...

Decibel Cannabis Raises $2 Million in the First Tranche of a Private Placement,

Nov 4, 2024

11:06 AM EST, 11/04/2024 (MT Newswires) -- Decibel Cannabis ( DBCCF ) on Monday completed a first closing of its non-brokered private placement, issuing 33.5-million shares at $0.06 each to raise $2 million. The initial tranche of the private placement was closed to provide insiders with an opportunity to participate. Over 75% of this first tranche subscribers were insiders, employees...